CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

What symbol and exchange does CNS Pharmaceuticals shares trade?

CNS Pharmaceuticals trades on the NASDAQ stock market under the symbol CNSP.

What is CNS Pharmaceuticals stock price doing today?

As of October 26, 2026, CNSP stock price declined to $4.63 with 2,118 million shares trading.

How much is CNS Pharmaceuticals worth?

CNSP has a market cap of $6.76 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price CNS Pharmaceuticals traded in the last 3 year period?

In the last 3 years, CNSP traded as high as $82,499.99 and as low as $1.90.

What are the top ETFs holding CNS Pharmaceuticals?

The top ETF exchange traded funds that CNSP belongs to (by Net Assets): VXF.

Is CNS Pharmaceuticals (CNSP) a good investment?

CNSP has underperformed the market in the last year with a price return of -44.0% while the SPY ETF gained +14.1%. CNSP has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -11.6% and -10.9%, respectively, while the SPY returned +3.8% and -1.6%, respectively.

What are the support and resistance levels for CNS Pharmaceuticals (CNSP)?

CNSP support price is $4.59 and resistance is $5.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CNSP shares will trade within this expected range on the day.